Bridge Creek Capital Management LLC held its position in Clorox Company (The) (NYSE:CLX) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,095 shares of the company’s stock at the end of the second quarter. Bridge Creek Capital Management LLC’s holdings in Clorox Company (The) were worth $279,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. American Beacon Advisors Inc. purchased a new position in shares of Clorox Company (The) during the first quarter valued at $104,000. Quadrant Capital Group LLC raised its position in shares of Clorox Company (The) by 23.0% in the first quarter. Quadrant Capital Group LLC now owns 846 shares of the company’s stock valued at $106,000 after buying an additional 158 shares during the period. Valley National Advisers Inc. raised its position in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. raised its position in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares during the period. Finally, Zions Bancorporation raised its position in Clorox Company (The) by 5.6% in the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock worth $134,000 after buying an additional 53 shares during the last quarter. 70.56% of the stock is currently owned by institutional investors and hedge funds.
Clorox Company (NYSE:CLX) traded down 0.70% during mid-day trading on Wednesday, reaching $132.20. The company’s stock had a trading volume of 362,511 shares. The firm’s 50 day moving average is $134.79 and its 200-day moving average is $133.07. The stock has a market cap of $17.03 billion, a P/E ratio of 26.12 and a beta of 0.40. Clorox Company has a one year low of $111.24 and a one year high of $141.76.
Clorox Company (The) (NYSE:CLX) last announced its earnings results on Wednesday, May 3rd. The company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.01. Clorox Company (The) had a net margin of 11.22% and a return on equity of 215.99%. The firm had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.48 billion. During the same period in the prior year, the firm earned $1.21 EPS. The firm’s revenue for the quarter was up 3.6% on a year-over-year basis. Equities analysts expect that Clorox Company will post $5.31 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 4th. Investors of record on Wednesday, July 19th will be paid a dividend of $0.84 per share. This is an increase from Clorox Company (The)’s previous quarterly dividend of $0.80. This represents a $3.36 annualized dividend and a yield of 2.52%. The ex-dividend date of this dividend is Monday, July 17th. Clorox Company (The)’s dividend payout ratio is presently 66.27%.
TRADEMARK VIOLATION WARNING: This article was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this article on another site, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The correct version of this article can be viewed at https://stocknewstimes.com/2017/08/02/bridge-creek-capital-management-llc-has-279000-position-in-clorox-company-the-clx-updated.html.
A number of equities analysts have recently commented on CLX shares. Vetr raised Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 price target for the company in a report on Monday, April 24th. Zacks Investment Research raised Clorox Company (The) from a “hold” rating to a “buy” rating and set a $151.00 price target for the company in a report on Wednesday, April 5th. BMO Capital Markets reiterated a “buy” rating and issued a $136.00 price objective on shares of Clorox Company (The) in a research report on Thursday, May 4th. Royal Bank Of Canada reiterated a “hold” rating and issued a $115.00 price objective on shares of Clorox Company (The) in a research report on Friday, June 30th. Finally, Jefferies Group LLC set a $138.00 price objective on Clorox Company (The) and gave the stock a “hold” rating in a research report on Wednesday, May 3rd. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $128.48.
Clorox Company (The) Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.
